Natco Pharma to enhance total investment in eGenesis to $25 million

Natco Pharma’s Canadian subsidiary will invest $13.7 million, while Natco Pharma USA LLC will contribute $3 million
More news in Industry
UCIL bets on greenfield mines, copper residue to double uranium output by 2036
Zydus launches in U.S. MSN Labs generic of Bayer’s PAH drug
Mphasis extends Social Security Scotland deal in £35.4 million contract